Jay Bhattacharya Appointed Acting Director of CDC Amid Controversy

Dr. Jay Bhattacharya, currently the director of the National Institutes of Health (NIH), has been appointed as the acting director of the Centers for Disease Control and Prevention (CDC). This appointment marks the fourth leadership change at the CDC within a year, following the departure of Jim O’Neill, who served as acting director since August 2025. Bhattacharya's dual role raises concerns about his capacity to effectively manage both agencies simultaneously, particularly given the significant challenges facing the CDC.

The Guardian

Bhattacharya's appointment comes amid a broader restructuring within the Department of Health and Human Services (HHS) under Secretary Robert F. Kennedy Jr. The CDC has faced scrutiny for its shifting vaccination policies, which have included recommendations to reduce the number of vaccines for children. Critics argue that these changes reflect a political agenda rather than scientific consensus. The previous CDC director, Susan Monarez, was ousted after just 29 days for refusing to comply with pressures to alter vaccine recommendations.

Jay Bhattacharya Tapped For Second Role Leading US Centers For Disease ControlThe HillThe Guardian

Critics have expressed skepticism regarding Bhattacharya's ability to lead effectively. Observers note that he has been largely hands-off in his role at NIH, delegating responsibilities to his deputy, Matthew Memoli. Jenna Norton, an NIH program officer, remarked that Bhattacharya's role appears more symbolic, serving as a figurehead for the administration's agenda. Former NIH director Jeremy Berg criticized Bhattacharya's leadership, stating, "I think he’s safely locked up the position of worst NIH director in history."

The Guardian

In response to Bhattacharya's appointment, Kennedy emphasized the need for leaders who can drive accountability and challenge entrenched interests in health policy. However, critics argue that Bhattacharya's close alignment with Kennedy's agenda raises concerns about potential conflicts of interest, particularly regarding vaccination policies. Dr. Debra Houry, a former CDC Chief Medical Officer, stated during her resignation that the agency had been reduced to "rubber stamps" for policies not based in science.

The Guardian

The appointment has drawn criticism from various health experts. Dr. James Alwine, an emeritus professor at the University of Pennsylvania, described the administration's approach as a new form of conflict of interest, promoting "Medical Freedom" while undermining public health. Concerns have also been raised about the potential resurgence of vaccine-preventable diseases, as evidenced by a recent spike in measles cases in South Carolina.

Jay Bhattacharya Tapped For Second Role Leading US Centers For Disease Control

Bhattacharya's tenure as acting director is temporary, lasting until a permanent successor is confirmed by the Senate. His leadership will be closely monitored as he navigates the challenges of managing both the NIH and CDC while addressing the ongoing public health implications of the administration's vaccination policies.

The Guardian

• “They needed someone confirmed by the Senate who won’t interfere,” — Dorit Reiss, Professor of Law, University of California

The Guardian

• “I think he’s safely locked up the position of worst NIH director in history.” — Jeremy Berg, Former Director, National Institute of General Medical Sciences

The Guardian

• “I resigned because CDC leaders were reduced to rubber stamps, supporting policies not based in science and putting American lives at risk,” — Dr. Debra Houry, Former CDC Chief Medical Officer

Jay Bhattacharya Tapped For Second Role Leading US Centers For Disease Control